Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

Clinical trial NCT07080242 · RECRUITING

Trial details

NCT number: NCT07080242
Sponsor: SystImmune Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer Metastatic or Locally Advanced Neuroendocrine Cancer Metastatic Neuroendocrine Prostate Cancer Metastatic Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma Metastatic Advanced Merkel Cell Carcinoma Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung Locally Advanced Extrapulmonary Neuroendocrine Carcinoma Locally Advanced Neuroendocrine Prostate Cancer Locally Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine Locally Advanced Merkel Cell Carcinoma Metastatic Large Cell Neuroendocrine Carcinoma of the Lung

Start date: 2025-04-28
Primary completion: 2027-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.